These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 7312923)

  • 21. Effect of short-term high dietary calcium intake on 24-h energy expenditure, fat oxidation, and fecal fat excretion.
    Jacobsen R; Lorenzen JK; Toubro S; Krog-Mikkelsen I; Astrup A
    Int J Obes (Lond); 2005 Mar; 29(3):292-301. PubMed ID: 15672116
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Absorption, distribution, metabolism, and excretion of griseofulvin in man and animals.
    Lin C; Symchowicz S
    Drug Metab Rev; 1975; 4(1):75-95. PubMed ID: 1106976
    [No Abstract]   [Full Text] [Related]  

  • 23. Effect of a high-fat meal on the bioavailability of phenytoin in a commercial powder with a large particle size.
    Hamaguchi T; Shinkuma D; Irie T; Yamanaka Y; Morita Y; Iwamoto B; Miyoshi K; Mizuno N
    Int J Clin Pharmacol Ther Toxicol; 1993 Jul; 31(7):326-30. PubMed ID: 8370631
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pharmacokinetic properties of combination oxycodone plus racemic ibuprofen: two randomized, open-label, crossover studies in healthy adult volunteers.
    Kapil R; Nolting A; Roy P; Fiske W; Benedek I; Abramowitz W
    Clin Ther; 2004 Dec; 26(12):2015-25. PubMed ID: 15823765
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Human pharmacology of griseofulvin: the effect of fat intake on gastrointestinal absorption.
    CROUNSE RG
    J Invest Dermatol; 1961 Dec; 37():529-33. PubMed ID: 13882411
    [No Abstract]   [Full Text] [Related]  

  • 26. Effect of food on the bioavailability of griseofulvin from microsize and PEG ultramicrosize (GRIS-PEG) plain tablets.
    Aoyagi N; Ogata H; Kaniwa N; Ejima A
    J Pharmacobiodyn; 1982 Feb; 5(2):120-4. PubMed ID: 7097474
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Study on the influence of food on the absorption of theophylline from a controlled-release preparation.
    Pabst G; Weber W; Müller M; Barkworth MF
    Arzneimittelforschung; 1994 Mar; 44(3):333-7. PubMed ID: 8192698
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The effect of a 12-week low glycaemic index diet on heart disease risk factors and 24 h glycaemic response in healthy middle-aged volunteers at risk of heart disease: a pilot study.
    Philippou E; McGowan BM; Brynes AE; Dornhorst A; Leeds AR; Frost GS
    Eur J Clin Nutr; 2008 Jan; 62(1):145-9. PubMed ID: 17311054
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Bioavailability of micronized griseofulvin from corn oil-in-water emulsion, aqueous suspension, and commercial tablet dosage forms in humans.
    Bates TR; Sequeria JA
    J Pharm Sci; 1975 May; 64(5):793-7. PubMed ID: 1151647
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Bioavailability of griseofulvin from plain tablets in Göttingen minipigs and the correlation with bioavailability in humans.
    Aoyagi N; Ogata H; Kaniwa N; Ejima A; Yasuda Y; Tanioka Y
    J Pharmacobiodyn; 1984 Jan; 7(1):7-14. PubMed ID: 6726615
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Role of food interaction pharmacokinetic studies in drug development. Food interaction studies of theophylline and nifedipine retard and buspirone tablets].
    Drabant S; Klebovich I; Gachályi B; Renczes G; Farsang C
    Acta Pharm Hung; 1998 Sep; 68(5):294-306. PubMed ID: 9805816
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Bioavailability of peroral antibiotic preparations].
    Zak AF
    Antibiotiki; 1977 Mar; 22(3):265-79. PubMed ID: 322606
    [No Abstract]   [Full Text] [Related]  

  • 33. Prediction of oral absorption of griseofulvin, a BCS class II drug, based on GITA model: utilization of a more suitable medium for in-vitro dissolution study.
    Fujioka Y; Kadono K; Fujie Y; Metsugi Y; Ogawara K; Higaki K; Kimura T
    J Control Release; 2007 Jun; 119(2):222-8. PubMed ID: 17442444
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Evaluation of in vivo dissolution behavior and GI transit of griseofulvin, a BCS class II drug.
    Fujioka Y; Metsugi Y; Ogawara K; Higaki K; Kimura T
    Int J Pharm; 2008 Mar; 352(1-2):36-43. PubMed ID: 18037251
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Is the association between dietary fat intake and insulin resistance modified by physical activity?
    Harding AH; Williams DE; Hennings SH; Mitchell J; Wareham NJ
    Metabolism; 2001 Oct; 50(10):1186-92. PubMed ID: 11586491
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Efficacy of a novel chitosan formulation on fecal fat excretion: a double-blind, crossover, placebo-controlled study.
    Barroso Aranda J; Contreras F; Bagchi D; Preuss HG
    J Med; 2002; 33(1-4):209-25. PubMed ID: 12939120
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Metabolism of griseofulvin-14C; studies in vivo.
    Symchowicz S; Wong KK
    Biochem Pharmacol; 1966 Oct; 15(10):1595-600. PubMed ID: 5971811
    [No Abstract]   [Full Text] [Related]  

  • 38. Griseofulvin---phenobarbital interaction: a formulation-dependent phenomenon.
    Jamali F; Axelson JE
    J Pharm Sci; 1978 Apr; 67(4):466-70. PubMed ID: 641749
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cardiovascular event risk in relation to dietary fat intake in middle-aged individuals: data from The Malmö Diet and Cancer Study.
    Leosdottir M; Nilsson PM; Nilsson JA; Berglund G
    Eur J Cardiovasc Prev Rehabil; 2007 Oct; 14(5):701-6. PubMed ID: 17925631
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Responses of surrogate markers of cholesterol absorption and synthesis to changes in cholesterol metabolism during various amounts of fat and cholesterol feeding among healthy men.
    Nissinen MJ; Gylling H; Miettinen TA
    Br J Nutr; 2008 Feb; 99(2):370-8. PubMed ID: 17697430
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.